GlobeNewswire 1/20/2022 Inventiva announces participation at several conferences in January and February 2022
GlobeNewswire 1/20/2022 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 1/20/2022 Royalty Pharma to Announce Fourth-Quarter and Full-Year 2021 Financial Results on February 15, 2022
GlobeNewswire 1/19/2022 CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-904 for t...
GlobeNewswire 1/12/2022 Mizuho Americas Hires Graig C. Suvannavejh, PhD, as Senior Biopharmaceuticals and Biotechnology Anal...
GlobeNewswire 1/10/2022 Royalty Pharma Highlights Accomplishments and Provides Business Update at 40th Annual J.P. Morgan He...
GlobeNewswire 1/10/2022 Frontier Medicines Announces Advancement of First Program Under Global Partnership with AbbVie
GlobeNewswire 1/7/2022 Coherus BioSciences Secures Credit Financing with Pharmakon Advisors
GlobeNewswire 1/7/2022 Royalty Pharma and Cytokinetics Announce Funding Agreements Totaling up to $450 Million
GlobeNewswire 1/7/2022 Cytokinetics and Royalty Pharma Announce Funding Agreements Totaling up to $450 Million
GlobeNewswire 1/6/2022 Adverum Biotechnologies Appoints Star Seyedkazemi, Pharm.D. as Chief Development Officer
GlobeNewswire 1/6/2022 Royalty Pharma Announces 12% Dividend Increase
GlobeNewswire 1/6/2022 Sosei Heptares and Verily will collaborate to generate novel drug candidates against GPCR targets fo...
GlobeNewswire 1/5/2022 Royalty Pharma to Present at the J.P. Morgan Healthcare Conference on January 10
GlobeNewswire 1/5/2022 CytomX Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 1/5/2022 Aspira Women’s Health Announces Fourth Quarter Operational Metrics and Provides Updates on Its OvaWa...
GlobeNewswire 1/5/2022 Morphic Therapeutic to Present at the Virtual 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 12/28/2021 Sosei Heptares to present at 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 12/24/2021 Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
GlobeNewswire 12/20/2021 CytomX Therapeutics Announces Preliminary Results for Ongoing Phase 2 Expansion Study of CX-2029, a ...
GlobeNewswire 12/20/2021 Women In Bio Elects Dr. Azurii Collier as 2022 President-Elect
GlobeNewswire 12/20/2021 Coherus Announces U.S. FDA Approval of YUSIMRY™ (adalimumab-aqvh)
GlobeNewswire 12/16/2021 Inventiva to present at the 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 12/16/2021 Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Nov...
GlobeNewswire 12/14/2021 Idera Pharmaceuticals Announces Tilsotolimod Updates